✦ LIBER ✦

PHOSPHOLIPASE A2INHIBITORS AND LEUKOTRIENE SYNTHESIS INHIBITORS BLOCK TNF-INDUCED NF-κB ACTIVATION

✍ Scribed by André A.F.L. van Puijenbroek; Sacha Wissink; Paul T. van der Saag; Maikel P. Peppelenbosch

Book ID: 115596246
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 164 KB
Volume: 11
Category: Article
ISSN: 1043-4666
DOI: 10.1006/cyto.1998.0404

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fijiolides A and B, Inhibitors of TNF-α-

Fijiolides A and B, Inhibitors of TNF-α-Induced NFκB Activation, from a Marine-Derived Sediment Bacterium of the Genus Nocardiopsis

✍ Nam, Sang-Jip; Gaudêncio, Susana P.; Kauffman, Christopher A.; Jensen, Paul R.; 📂 Article 📅 2010 🏛 American Chemical Society 🌐 English ⚖ 497 KB

Protein Synthesis Inhibitors Cycloheximi

Protein Synthesis Inhibitors Cycloheximide and Anisomycin Induce Interleukin-6 Gene Expression and Activate Transcription Factor NF-κB

✍ Laura Faggioli; Chiara Costanzo; Marcello Merola; Adriana Furia; Marta Palmieri 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 853 KB

Tyrosine Kinase Inhibitors, Genistein an

Tyrosine Kinase Inhibitors, Genistein and Herbimycin A, Do Not Block Interleukin-1 β-Induced Activation of NF-κB in Rat Mesangial Cells

✍ Toshifumi Tetsuka; Sunil K. Srivastava; Aubrey R. Morrison 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Specific IKKβ inhibitor IV blocks strept

Specific IKKβ inhibitor IV blocks streptonigrin-induced NF-κB activity and potentiates its cytotoxic effect on cancer cells

✍ Maria Gavriil; Cheng-Chung Tsao; Sreekala Mandiyan; Kim Arndt; Robert Abraham; Y 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

## Abstract Many anticancer agents activate NF‐κB, which plays an important role in the survival of cancer cells. Inhibition of NF‐κB activity may therefore potentiate the efficacy of anticancer agents. We found that a previously used anticancer agent Streptonigrin (SN) was also a potent NF‐κB indu

A novel NF-κB inhibitor DHMEQ selectivel

A novel NF-κB inhibitor DHMEQ selectively targets constitutive NF-κB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo

✍ Mariko Watanabe; Md. Zahidunnabi Dewan; Takamitu Okamura; Masataka Sasaki; Kinji 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 453 KB

Multiple myeloma (MM) is a fatal lymphoid malignancy that is incurable with conventional modalities of chemotherapy. Strong and constitutive activation of nuclear factor kappa B (NF-kappaB) is a common characteristic of MM cells. In our study we successfully target NF-kappaB with a novel NF-kappaB i

Activation of cytosolic phospholipase A2

Activation of cytosolic phospholipase A2 in human T-lymphocytes involves inhibitor-κB and mitogen-activated protein kinases

✍ Elke Burgermeister; Josef Endl; Werner V. Scheuer 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 550 KB